Predictor | Median value of continuous predictors | Acceptance rates (yes vs. no or above vs. below median) | Bivariate models | Multivariable model | ||
---|---|---|---|---|---|---|
 |  |  | IRR (95% CI) | P | IRR (95% CI) | p |
 For best practice advisories (BPAs) | ||||||
  Clinician characteristics | ||||||
   Nurse practitioner (vs physician) | -- | 22.7% vs 21.0% | 1.08 (0.74, 1.57) | .69 | 0.79 (0.57-1.10) | .16 |
   Attested for meaningful use (vs not attested) | -- | 22.9% vs 19.3% | 1.19 (0.94, 1.51) | .15 | 1.06 (0.88-1.28) | .50 |
   Female (vs male) | -- | 23.0% vs 18.4% | 1.25 (0.98, 1.59) | .07 | 1.06 (0.88-1.27) | .54 |
  Markers of workload | ||||||
   Patients per year | 790 | 20.7% vs 21.7% | 1.002 (0.98, 1.02)c | .85 | ---f |  |
   Encounters per year | 1357 | 21.8% vs 20.6% | 0.999 (0.99, 1.01)d | .92 | 1.01 (1.00-1.02) | .21 |
  Markers of complexity | ||||||
   BPAs received per encounter | 3.2 | 15.8% vs 26.7% | 0.65 (0.55, 0.77)a | <.001 | 0.70 (0.60-0.82) | <.001 |
   Drug alerts received per encounter | 0.7 | 22.7% vs 19.8% | 1.17 (0.80, 1.72)a | .41 | 1.91 (1.39-2.64) | <.001 |
   Average ADG comorbidity count of patients | 0.3 | 18.9% vs 23.5% | 0.27 (0.10, 0.71)b | .008 | 0.49 (0.23-1.03) | .06 |
   Percent of BPAs that are within-patient repeats | 26.2 | 17.0% vs 25.4% | 0.90 (0.87, 0.94)e | <.001 | 0.90 (0.86-0.95) | <.001 |
 For drug alerts (DDI and DAI) | ||||||
  Clinician characteristics | ||||||
   Nurse practitioner (vs physician) | -- | 0.9% vs 0.2% | 3.97 (1.64, 9.62) | .002 | 4.56 (1.72-12.06) | .002 |
   Attested for meaningful use (vs not attested) | -- | 0.3% vs 0.3% | 0.92 (0.40, 2.11) | .85 | 0.96 (0.49-1.88) | .91 |
   Female (vs male) | -- | 0.4% vs 0.2% | 1.72 (0.82, 3.60) | .15 | 0.85 (0.37-1.95) | .71 |
  Markers of workload | ||||||
   Patients per year | 790 | 0.3% vs 0.3% | 0.99 (0.94, 1.04)c | .60 | -----f |  |
   Encounters per year | 1357 | 0.3% vs 0.4% | 0.98 (0.96, 1.01)d | .12 | 1.00 (0.97-1.04) | .82 |
  Markers of complexity | ||||||
   BPAs received per encounter | 3.2 | 0.3% vs 0.3% | 1.10 (0.78, 1.56)a | .59 | 1.49 (1.03-2.17) | .04 |
   Drug alerts received per encounter | 0.7 | 0.2% vs 0.4% | 0.69 (0.29, 1.67)a | .42 | 1.39 (0.44-4.39) | .57 |
   Average ADG comorbidity count of patients | 0.3 | 0.3% vs 0.4% | 0.15 (0.03, 0.80)b | .03 | 0.37 (0.05-2.74) | .33 |
   Percent of alerts that are within-patient repeats | 31.8 | 0.3% vs 0.4% | 0.87 (0.76, 0.998)e | .046 | 0.84 (0.68-1.03) | .09 |
   Order sets used per encounter | 1.1 | 0.3% vs 0.3% | 1.20 (0.44, 3.23)a | .72 | 1.68 (0.76-3.71) | .20 |
   Labs ordered per encounter | 0.9 | 0.3% vs 0.3% | 0.89 (0.43, 1.83)a | .75 | 0.80 (0.41-1.56) | .51 |